How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/idiopathic-generalized-epilepsy.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Idiopathic generalized epilepsy — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Idiopathic generalized epilepsy (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Idiopathic generalized epilepsy, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Fycompa	PERAMPANEL	Catalyst Pharms	Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]	Glutamate receptor ionotropic AMPA	2012-01-01
Vimpat	lacosamide	UCB		Dihydropyrimidinase-related protein 2, Carbonic anhydrase 1, Carbonic anhydrase 12
Fycompa	Fycompa	Eisai Inc.		Glutamate receptor ionotropic AMPA

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Catalyst Pharms · 1 drug in Idiopathic generalized epilepsy
Eisai Inc. · 1 drug in Idiopathic generalized epilepsy
UCB · 1 drug in Idiopathic generalized epilepsy

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Idiopathic generalized epilepsy:

Cite this brief

Drug Landscape (2026). Idiopathic generalized epilepsy — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/idiopathic-generalized-epilepsy. Accessed 2026-06-10.

Idiopathic generalized epilepsy full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing